Beyond Dual Therapy: Rethinking Tegoprazan–Amoxicillin for H. pylori

{"A":[0],"Systematic":[1],"Review":[2],"and":[3,23,34],"Meta-Analysis":[4],"With":[5],"Trial":[6],"Sequential":[7],"Analysis":[8],"of":[9,21,53],"Randomized":[10],"Controlled":[11],"Trials\\"":[12],"by":[13],"Zhou":[14],"et":[15],"al.":[16],"published":[17],"in":[18],"the":[19,27],"Journal":[20],"Gastroenterology":[22],"Hepatology":[24],"[1].We":[25],"appreciate":[26],"authors":[28],"for":[29,57],"conducting":[30],"this":[31],"systematic":[32],"review":[33],"meta-analysis":[35],"with":[36],"trial":[37],"sequential":[38],"analysis,":[39],"which":[40],"synthesizes":[41],"evidence":[42],"from":[43],"randomized":[44],"controlled":[45],"trials":[46],"to":[47],"provide":[48],"a":[49],"more":[50],"robust":[51],"evaluation":[52],"tegoprazan-amoxicillin":[54],"dual":[55],"therapy":[56],"H.":[58],"pylori":[59],"eradication.However,":[60],"several":[61],"methodological":[62],"considerations":[63],"warrant":[64],"further":[65],"consideration.":[66]}